Mankind Pharma Secures CCI Nod for $1.64 billion Bharat Serums Acquisition
Mankind Pharma has received approval from the Competition Commission of India (CCI) for the acquisition of Bharat Serums and Vaccines (BSV) for $1.64 billion. The…
Mankind Pharma has received approval from the Competition Commission of India (CCI) for the acquisition of Bharat Serums and Vaccines (BSV) for $1.64 billion. The…
Mankind Pharma, a prominent player in the Indian OTC drug market, has finalised the acquisition of Bharat Serums and Vaccines (BSV) from global investor Advent…
Mankind Pharma is a company operating in the pharmaceutical industry. At Mankind Pharma, we aspire to aid the community in leading a healthy life by…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.